
News|Articles|March 1, 2002
Direct thrombin inhibitors top heparin in ACS
Direct thrombin inhibitors are superior to heparin in preventing death or myocardial infarction (MI) in patients with acute coronary syndromes (ACS), according to a meta-analysis of 11 randomized trials.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
PBM Reform Debate: Panelists Clash Over Spread Pricing and Rebates | AMCP Nexus 2025
2
Cigna Announces ‘Rebate-Free’ Pharmacy Benefit Model Starting in 2027
3
Rebates Play a Major Role in Whether Health Plans Restrict Access to Specialty Drugs | AMCP Nexus 2025
4
Whole Health and Pharmacy: The Overlooked Alliance in Chronic Disease Management
5


















































